← Leaderboards
Junghae Suh
University Of Texas Hlth Sci Ctr Houston
$3,966,192
Attributed
$8,204,346
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2009–21$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,204,346 · 6
By mechanism
R01$3,768,115 · 2
RC2$3,001,830 · 1
R21$808,712 · 2
T32$625,689 · 1
Top collaborators
- Gang Bao5 shared
- Wah Chiu3 shared
- Paolo Decuzzi3 shared
- Rebekah A. Drezek3 shared
- Mauro Ferrari3 shared
- David G. Gorenstein3 shared
- Jim Klostergaard3 shared
- Chun Li3 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Paolo Decuzzi$1,404,711
- Rebekah A. Drezek$1,185,842
- Jim Klostergaard$250,153
- Ba-Bie Teng$3,407,703
Others in their field
Top investigators on “Property”
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
PropertyCellsResearch PersonnelBaseGene TherapyOrganCellular TransductionGenesReceptorDetectionGenerationsCapsidLeadLiverExtracellularImmune ResponseGene DeliveryExposure ToDependovirusDoseIn VivoDesignAdeno-Associated Viral VectorPeptide Hydrolases
Grant awards (18)
Targeted Gene Therapy of Heart Failure Post Myocardial Infarction$467,852
R01 · FY2021 · HL
Targeted Gene Therapy of Heart Failure Post Myocardial Infarction$473,855
R01 · FY2020 · HL
Provectors for treatment of ovarian cancer$352,623
R01 · FY2020 · CA
Targeted Gene Therapy of Heart Failure Post Myocardial Infarction$502,327
R01 · FY2019 · HL
Provectors for treatment of ovarian cancer$342,044
R01 · FY2019 · CA
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$182,902
T32 · FY2019 · CA
Targeted Gene Therapy of Heart Failure Post Myocardial Infarction$558,620
R01 · FY2018 · HL · contact PI
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$442,787
T32 · FY2018 · CA
Provectors for treatment of ovarian cancer$352,623
R01 · FY2018 · CA · contact PI
Provectors for treatment of ovarian cancer$352,623
R01 · FY2017 · CA · contact PI
Provectors for treatment of ovarian cancer$365,548
R01 · FY2016 · CA · contact PI
MMP-targeted viral gene delivery vectors for treatment of infarcted heart$187,588
R21 · FY2016 · HL · contact PI
MMP-targeted viral gene delivery vectors for treatment of infarcted heart$240,150
R21 · FY2015 · HL · contact PI
Matrilysin-Sensing Gene Delivery Vectors for Colorectal Cancer Therapy$166,639
R21 · FY2015 · CA · contact PI
Matrilysin-Sensing Gene Delivery Vectors for Colorectal Cancer Therapy$214,335
R21 · FY2014 · CA · contact PI
Subcellular localization of nanoparticles$993,315
RC2 · FY2010 · GM
Subcellular localization of nanoparticles$495,098
RC2 · FY2010 · GM
Subcellular localization of nanoparticles$1,513,417
RC2 · FY2009 · GM